Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only,...
FDA Recall #D-0604-2016 — Class II — August 19, 2015
Product Description
Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.
Reason for Recall
Stability data does not support expiry.
Recalling Firm
Pharmakon Pharmaceuticals — Noblesville, IN
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
400
Distribution
Nationwide
Code Information
All lots with expiration dates up to 11/17/2015
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated